Evidence map›Paper›PMID 41803379›Full record

ArticleMolecular psychiatry2026

Deciphering the causal influence of BMI and related metabolic, inflammatory, and cardiovascular factors on brain structure: a Mendelian Randomization Study.

Jodie N Painter, Alexander Refisch, Moritz Rau, Martin Walter, Scott Mackey, Jennifer Laurent, Paul M Thompson, Katrina L Grasby, Tomas Hajek, Sarah E Medland and 1 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jodie N PainterBrain and Mental Health Program, QIMR Berghofer, Herston, QLD, Australia.ORCID http://orcid.org/0000-0002-4992-2458
Alexander RefischDepartment of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.ORCID http://orcid.org/0000-0002-3505-1575
Moritz RauDepartment of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.ORCID http://orcid.org/0009-0000-8040-4926
Martin WalterDepartment of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.ORCID http://orcid.org/0000-0001-7857-4483
Scott MackeyDepartment of Psychiatry, University of Vermont, Burlington, VT, USA.ORCID http://orcid.org/0000-0001-7817-7437
Jennifer LaurentDepartment of Nursing, University of Vermont, Burlington, VT, USA.
Paul M ThompsonUniversity of Southern California Keck School of Medicine, Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Los Angeles, California, USA.
Katrina L GrasbyBrain and Mental Health Program, QIMR Berghofer, Herston, QLD, Australia.ORCID http://orcid.org/0000-0001-8539-0228
Tomas HajekDepartment of Psychiatry, Dalhousie University, Halifax, NS, Canada.ORCID http://orcid.org/0000-0003-0281-8458
Sarah E MedlandBrain and Mental Health Program, QIMR Berghofer, Herston, QLD, Australia.ORCID http://orcid.org/0000-0003-1382-380X
Nils OpelDepartment of Psychiatry & Neuroscience, Campus Benjamin Franklin, Charité Universitätsmedizin, Berlin, Germany. nils.opel@charite.de.ORCID http://orcid.org/0000-0003-4749-3298

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01EE2305ADepartment of Health | National Health and Medical Research Council (NHMRC) APP1158127Department of Health | National Health and Medical Research Council (NHMRC) APP1163040Department of Health | National Health and Medical Research Council (NHMRC) APP1172917Department of Health | National Health and Medical Research Council (NHMRC) APP1173025Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 142255Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 180449Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) 186254
6 · The paper itself

Abstract

Obesity is a highly prevalent metabolic risk factor that commonly coincides with additional metabolic, cardiovascular, and inflammatory abnormalities. Obesity has frequently been shown to affect brain physiology at multiple levels, and to increase the risk for the development of neuropsychiatric disorders such as major depression and dementia. Previous large-scale neuroimaging research has consistently shown overlapping brain structural alterations in obesity and neuropsychiatric disorders, with the most pronounced alterations being lower cortical thickness in the frontal and temporal cortex. Yet, the direction of association, and the potential causal effect of obesity on brain structural decline, remains unclear. Moreover, it is imperative to determine which of the multifaceted biological systems impacted by obesity, encompassing metabolic, cardiovascular, and inflammatory aspects, may be implicated in the link between obesity and brain structural decline. In this study, we employed univariate and multivariate Mendelian randomization (MR) as an instrumental variable (IV) approach to clarify the causal direction of the relationship between body mass index (BMI) and brain structure and to disentangle the metabolic, cardiovascular, and inflammatory factors that might underlie this relationship. We found evidence for a potential causal influence of elevated BMI on lower cortical thickness, with the most prominent effects in the precentral and fusiform gyrus. We furthermore found concurrent nominal associations of visceral adipose tissue (VAT) and the inflammatory serum marker CRP with lower cortical thickness which largely overlapped with regions associated with higher BMI. In contrast, very few associations with cortical thickness emerged for blood pressure or metabolic serum markers. Our findings thus corroborate the notion of a causal effect of BMI on lower cortical thickness. Future research should aim to delineate if and how the BMI related effect on brain structural decline conveys an increased risk for the development of neuropsychiatric disorders.

Indexed as

BrainBody Mass IndexCardiovascular DiseasesHumansInflammationMagnetic Resonance ImagingMaleMendelian Randomization AnalysisObesityRisk Factors

Identifiers

PMID41803379
PMCPMC13268969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.